Medical Device Industry

Found 9,132 articles

• Avania Acquires IMARC, Global Medical Device CRO

  6/22/2021

  Avania , a leading global medical technology CRO, today announced its acquisition of IMARC, a highly respected medical device CRO headquartered in Strongsville, Ohio and providing service throughout the United States.

• Cardiac Insight Announces 4th Generation of Its Cardea SOLO™ ECG Monitoring System

  6/22/2021

  Cardiac Insight, Inc. (“Cardiac Insight” or the “Company”) is a healthcare innovator specializing in wearable cardiac sensors and proprietary software that automatically analyzes electrocardiogram (ECG) data to improve early detection and diagnosis of cardiac arrythmias, such as atrial fibrillation (AFib).

• Garwood Medical Devices and Integrum Discuss Commercial Collaboration To Conduct Joint Research to Expand Treatment Indications for The OPRA™ Implant System

  6/22/2021

  Garwood Medical Devices, LLC, an emerging Buffalo-based company developing groundbreaking BioPrax™ technology to eliminate antibiotic-resistant bacterial biofilm infections associated with implants, has signed a memorandum of understanding with Integrum AB (Nasdaq First North Growth Market: INTEG B), a worldwide leader in helping individuals with amputations improve their quality of life through Integrum's OPRA™ Implant System.

• Trudell Medical Group Makes a Strategic Investment in Xenocor, Developer of the Xenoscope

  6/22/2021

  The First Single-Use, Fog-Free, Portable, HD Laparoscopic Imaging System, Delivers Significant Clinical and Cost-Effective Advantages

• BD Highlights Five-Year ESG Achievements in 2020 Sustainability Report, Setting the Foundation for 2030+ Strategy

  6/22/2021

  BD, a leading global medical technology company, issued its 2020 Sustainability Report, highlighting significant achievements in environmental, social and governance factors that supported the company's 2020 Sustainability Goals – a five year strategy that concluded in 2020.

• Avisa Diagnostics Appoints G. Michael Landis as Chief Financial Officer

  6/22/2021

  Avisa Diagnostics Inc., a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load in post-COVID-19 long haulers and for ventilator-associated pneumonia, is pleased to announce that G. Michael Landis has joined Avisa as Chief Financial Officer, effective immediately.

• Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific Sessions

  6/22/2021

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that data from the SENZA Painful Diabetic Neuropathy Randomized Controlled Trial will be presented at the American Diabetes Association 81st Scientific Sessions virtual meeting, June 25-29, 2021.

• Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual Meeting

  6/22/2021

  Nevro Corp. announced that data from the SENZA Non-Surgical Refractory Back Pain Randomized Controlled Trial will be presented at the American Society of Interventional Pain Physicians 23rd annual meeting to be held in person from June 24-26, 2021 at the Hilton New Orleans Riverside in New Orleans, Louisiana.

• World's First Heart Valve Replacement Using Extended Reality Platform Brings the Operating Room to the Remote Surgical Specialist for Virtual Support During Live Procedures

  6/21/2021

  The Jewish General Hospital (JGH), a member facility of the West-Central Montreal Health Authority (CIUSSS), together with Auger Groupe Conseil Inc. (AGC) and Medtronic Canada ULC ― a subsidiary of Medtronic plc (NYSE:MDT) ― have pioneered the first application of the Microsoft HoloLens for use in real-time, extended reality (XR) clinical support of a minimally invasive heart procedure.

• Implantable Brain Device Relieves Pain in Early Study

  6/21/2021

  A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study finds.

• Intelivation Technologies Launches TruTrack™ Memory Staple System

  6/21/2021

  Intelivation Technologies, a medical device company with a cutting edge lower extremity portfolio announced that they are launching the TruTrackTM Memory Staple System.

• QualiMed Innovative Medizinprodukte GmbH, a Q3 Medical Devices Ltd Company, Receives European CE Mark Approval for UNITY-B™ Percutaneous Balloon Expandable Biodegradable Biliary Stent

  6/21/2021

  QualiMed Innovative Medizinprodukte GmbH, a wholly owned subsidiary of Dublin, Ireland based Q3 Medical Devices Limited (Q3), announced that it has received CE mark approval for a dedicated percutaneous biodegradable metal alloy based stent implant for biliary applications, the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent (BEBS)

• Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer

  6/21/2021

  Ethicon announced the launch of the ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency1 and provided stronger sealing2 and better access to more tissue than LigaSure™ Maryland.3 The device is indicated for colorectal, gynecological, bariatric surgery and thoracic procedures.

• Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire

  6/21/2021

  Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced that it has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health of the Food and Drug Administration for its Clotild® Smart Guidewire System designed to improve the treatment of ischemic stroke patients.

• Inogen Announces Appointment of General Counsel

  6/21/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.

• Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

  6/21/2021

  Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its fourth quarter fiscal year 2021, ended March 31, 2021, at 4:15 p.m. ET on Thursday, June 24, 2021

• Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference

  6/18/2021

  Avanos Medical, Inc. announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.

• Largest Real-World Registry Supporting Neovasc Reducer™ Safety and Efficacy Outcomes Published in International Journal of Cardiology

  6/18/2021

  Neovasc Inc. announced the publication of an article entitled, “Safety and Efficacy of Coronary Sinus Narrowing in Chronic Refractory Angina: Insights from the RESOURCE Study” in the International Journal of Cardiology.

• Sciton Celebrates the Newest Innovation in United Kingdom: Sciton's mJOULE

  6/18/2021

  Sciton® Inc., a leading manufacturer of medical and aesthetic lasers and light source technologies based in Palo Alto, California, announces the launch of its latest platform, mJOULE, in the United Kingdom.

• Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study

  6/18/2021

  The ongoing clinical study for our AcuVid™ COVID-19 Rapid Antigen Saliva Test has performed extremely well," expressed Therma's CEO Rob Fia.